Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,385 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

for
Lymphoid Leukemia
Location: Chicago IL, Milwaukee WI, Grand Rapids MI,
Sponsor: Stanford University

Sex: All

Age: 0 - 26

Code: NCT05865301

Recruiting
Active & Responsive

Study of Oral Food Challenge Biomarkers (SAFER)

for
Allergy
Location: Chicago IL, Ann Arbor MI, Nashville TN, Little Rock AR,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 1 - 17

Code: NCT07279467

Recruiting
Active & Responsive

PheCheck™ Validation Study

for
Phenylketonuria (PKU) and Hyperphenylalaninemia
Location: Chicago IL
Sponsor: Aptatek BioSciences, Inc

Sex: All

Age: 1+

Code: NCT07551921

Recruiting
Active & Responsive

A Study of MZE782 in Adults With PKU

for
Phenylketonuria (PKU)
Location: Chicago IL, Indianapolis IN, Lexington KY, Memphis TN,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07694440

Phase 2, Recruiting
Active & Responsive

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

for
HIV-1-infection, Breastfeeding, Pregnancy Related
Location: Chicago IL, Aurora CO
Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Sex: All

Age: 0+

Code: NCT07293559

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

for
Spinal Muscular Atrophy (SMA)
Location: Chicago IL, Iowa City IA, Little Rock AR,
Sponsor: argenx

Sex: All

Age: 5 - 17

Code: NCT07287982

Phase 2, Recruiting
Active & Responsive

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

for
Phenylketonuria
Location: Chicago IL, Nashville TN, Pittsburgh PA, Dallas TX,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 4+

Code: NCT06971731

Phase 3, Recruiting
Active & Responsive

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for
Congenital Adrenal Hyperplasia,
Location: Chicago IL, Ann Arbor MI, Minneapolis MN,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 1 - 17

Code: NCT07159841

Phase 2, Phase 3, Recruiting
Active & Responsive

Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

for
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation,
Location: Chicago IL, Minneapolis MN, Boston MA, Los Angeles CA
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)

Sex: All

Age: 12 - 17

Code: NCT07286292

Phase 2, Recruiting
Active & Responsive

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

for
Cytomegalovirus Prophylaxis
Location: Chicago IL, Madison WI, Ann Arbor MI, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07199465

Phase 1, Recruiting
Active & Responsive

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

for
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\),
Location: Chicago IL, Iowa City IA, Cincinnati OH, St Louis MO,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 5

Code: NCT06503367

Recruiting
Active & Responsive

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

for
Immunization; Infection, Transplantation Infection, Influenza
Location: Chicago IL, Indianapolis IN, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 17

Code: NCT05947071

Phase 2, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Chicago IL, Milwaukee WI, Ann Arbor MI, Cincinnati OH,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase 3, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Chicago IL, Kalamazoo MI, Madison WI, Grand Rapids MI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase 3, Recruiting
Active & Responsive

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Chicago IL, Cincinnati OH, Nashville TN, Rogers AR,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 3+

Code: NCT02523118

Recruiting
Active & Responsive

Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone Technology and E-coaching

for
Spinal Cord Injuries
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab

Sex: All

Age: 18 - 70+

Code: NCT05424172

Recruiting
Active & Responsive

Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia

for
Spinal Cord Injury
Location: Chicago IL, Hines IL
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70

Code: NCT05157282

Recruiting
Active & Responsive

Surgical Approach to Uterine Septum

for
Uterine Septum, Surgical Complication, Septum; Uterus,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 22 - 44

Code: NCT06315582

Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Chicago IL, Oak Park IL, Evanston IL, Oak Brook IL,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Chicago IL, Ottawa IL, Peru IL, Princeton IL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase 2, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Article preview image

Looking for women's health studies in Chicago? Read our guide: Top 10 Women's Health Clinical Trials in Chicago

Top 10 Women’s Health Clinical Trials in Chicago

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago